Notably, only 6/19 (32%) of Palb2-CKO mice developed mammary tumors (Fig 1C), likely due to a mostly C57BL/6 genetic background, which is known to be more resistant to mammary tumorigenesis. This evidence concerns the gene PALB2 and breast cancer.